C
onvulsive status epilepticus is a major medical emergency in which continuous or rapidly repeating seizures can cause death or permanent brain damage (1, 2) . Although convulsive status epilepticus was traditionally defined as seizure activity for Ͼ30 mins, experimental studies established that shorter periods of seizure activity could cause brain damage (3) . Therefore, to avoid undertreatment, the definition was changed to continuous seizure activity for Ͼ5-10 mins or more than two seizures without return to the previous level of consciousness in the interval (1, 4) . Convulsive status epilepticus manifests as motor seizure activity, as opposed to electrographic or nonconvulsive status epilepticus. Convulsive status epilepticus can be generalized or partial (5) . In generalized convulsive status epilepticus, the clinical manifestations are diffuse and consciousness is usually impaired (5) . Partial convulsive status epilepticus is characterized by onset in one part of the body, with or without subsequent generalization. Impaired consciousness accompanying partial motor seizures defines complex partial convulsive status epilepticus (6) .
The incidence of status epilepticus has been estimated at 10 -40 episodes per 100,000 population (7, 8) , and the direct costs estimated based on the number and length of hospital admissions are high compared to those of other common emergencies such as myocardial infarction, congestive heart failure, or intracranial hemorrhage (9) .
In the short term, approximately 25% of patients with convulsive status epilepticus die overall and approximately 40% die when seizure activity persists despite treatment (10) . Furthermore, among patients still alive 30 days after an episode, 43% died within 10 yrs (11) . Survivors may experience impaired cognitive function, motor deficits, and worsening of previous epilepsy or residual epilepsy after de novo convulsive status epilepticus (12, 13) . In a retrospective cohort study of patients with de novo status epilepticus, Glasgow Outcome Scale (GOS) scores at hospital discharge were markedly worse in patients with refractory seizure activity than in other patients (14) . The GOS has been found valid, practical, and reliable (15) . This tool is chiefly used for evaluating overall outcomes of neurologic conditions (14, 16 -18) and therefore appears well suited to an assessment of physical and functional burden after convulsive status epilepticus.
Previous studies of outcomes after convulsive status epilepticus produced divergent results, perhaps in part because of their retrospective design and use of varying definitions of status epilepticus (6, 13, 19) . Furthermore, despite shortterm mortality rates of up to 25%, few data have been reported on intensive care unit (ICU) admission or use of lifesustaining treatments (6, 20) . The outcome variable of interest was short-term mortality, and no data on long-term mortality or functional outcomes were obtained (20, 21) . Four retrospective observational studies reported ICU mortality rates in patients with status epilepticus (10, 13, 14, 22) . In an 8-yr retrospective study of ICU patients with status epilepticus, we found that the strongest predictors of hospital mortality were continuous (as opposed to intermittent) seizure activity, refractory seizure activity, and cerebral insult (10) .
No prospective studies are available on morbidity and mortality associated with convulsive status epilepticus in adults requiring ICU admission. We conducted a prospective multicenter observational cohort study of adult ICU patients with convulsive status epilepticus to determine mortality and functional outcomes over the first 90 days and to identify factors associated with a full recovery. We included 248 patients in 18 ICUs over a 2-yr period. After completing this CME activity, participants should be better able to identify the etiology of convulsive status epilepticus, evaluate prognosis, and anticipate course of the disease.
MATERIALS AND METHODS
The Ethics Committee of the French Society for Critical Care approved this prospective observational study.
Patients
Patients admitted to any of the 18 participating ICUs (listed in the Appendix) between June 2005 and June 2007 were prospectively included in the study if they were at least 18 yrs of age and had convulsive status epilepticus as defined. Patients with postanoxic status epilepticus were not included.
Objectives: Few outcome data are available about convulsive status epilepticus managed in the intensive care unit. We studied 90-day functional outcomes and their determinants in patients with convulsive status epilepticus. 
Definitions
Convulsive status epilepticus was defined as continuous motor seizure activity for at least 10 mins (continuous) (14) or as more than two motor seizures without full recovery of consciousness in the interval (intermittent) (23) . Refractory status epilepticus was defined as continuous or intermittent seizures despite treatment with an intravenous benzodiazepine (clonazepam or diazepam) and intravenous phenytoin, fosphenytoin, or phenobarbital (14) . Electrographic status epilepticus was diagnosed in comatose patients with or without subtle convulsive movements (rhythmic twitching of the arms, legs, trunk, or facial muscles; tonic eye deviation; or nystagmoid eye jerking) (23) but with generalized ictal discharges on the electroencephalogram (EEG) (24) .
Assessment of Outcome
The primary evaluation criterion was the structured GOS score on day 90 (Ϯ7 days) after ICU discharge ( Table 1 ). The GOS score reflects both mortality and morbidity (16) . Each surviving patient was interviewed on day 90 by a trained physician for GOS score determination (16) . When the patient was unable to complete the interview or could not be contacted, the GOS score was determined by interviewing the patient's general practitioner or neurologist. For this study, we defined a favorable outcome as a GOS score of 5, which is alive with good function enabling the return to former occupational or academic activities, with or without minor physical or mental deficits.
Statistical Analysis
Quantitative parameters are reported as median (interquartile range [IQR] ) and quali- ¥ Function was evaluated on day 90 in 224 of the 248 patients. † The primary outcome measure was the score on the Glasgow Outcome Scale 90 days after admission for convulsive status epilepticus. A score of 1 indicates death, 2 indicates a vegetative state (the patient is unable to interact with the environment), 3 indicates severe disability (the patient is unable to live independently but can follow commands), 4 indicates moderate disability (the patient is capable of living independently but unable to return to work or school), and 5 indicates mild or no disability (the patient is able to return to work or school). A favorable outcome was defined as a score of 5 and an unfavorable outcome was defined as a score Ͻ5. ICU, intensive care unit; GOS, Glasgow Outcome Scale. This indicates that a patient is conscious but needs the assistance of another person for some activities of daily living every day. This may range from continuous total dependency to the need for assistance with only one activity. 4 Moderate Patient is capable of living independently but unable to return to work or school disability Such patients are able to look after themselves at home, to get out and about to the shops, and to travel by public transport. However, some previous activities, either at work or in social life, are now no longer possible by reason of either physical or mental deficit. 5
Mild or no Patient is able to return to work or school disability This indicates the capacity to resume normal occupational and social activities, although there may be minor physical or mental deficits. However, for various reasons, the patient may not have resumed all previous activities and, in particular, may not be working.
Adapted from Jennett et al (16) .
tative parameters as number (%). Categorical variables were compared using Fisher's exact tests and continuous variables were compared using Wilcoxon's rank sum tests.
Patients whose 90-day GOS score was not determined were excluded from the analysis. To identify associations between patient characteristics and having a 90-day GOS score of 5, we used a logistic mixed-effect model to take into account a potential center effect. Variables yielding p Ͻ .20 in the univariate analysis and that were clinically relevant were considered for the multivariable model. All tests were two sided at the .05 significance level. Analyses were performed using the R statistical package (http://www.R-project.org; Free Software Foundation's GNU General Public License, Wien, Austria).
RESULTS
The patient flow chart is shown in Figure 1 . Of the 366 patients admitted to the 18 study ICUs for seizures during the 24-month study period, 95 did not meet inclusion criteria and 23 had postanoxic status epilepticus, leaving 248 patients for the study.
On-Scene Presentation
Patient characteristics are shown in Table 2. There were 99 women and 149 men, with a median age of 53 yrs (IQR, 42-64). A previous history of epilepsy was noted in 118 (48%) patients. Most episodes (167/ 248; 67%) occurred at out-of-hospital locations, and 209 (84%) were witnessed from the start. All but 15 patients were still seizing at medical team arrival. The median Glasgow Coma Scale (GCS) score was 5 (IQR, [3] [4] [5] [6] [7] [8] , and focal neurologic signs were noted on-scene in 82 (33%) patients.
Management in the ICU
The median time from medical team arrival to anticonvulsant drug initiation was 5 mins (IQR, 0 -15), and the median time from seizure onset to anticonvulsant drug initiation was 40 mins (IQR, 5-80). Treatment modalities are reported in Table  2 . The median number of anticonvulsant treatment lines was one (IQR, 1-2), and the median number of anticonvulsant drugs needed to control the seizures was two (IQR, 1-2). Anticonvulsant drug therapy was maintained throughout the ICU stay in all patients except those with status epilepticus related to metabolic disorders or drug poisoning. The seizures proved refractory in 49 (20%) patients, in whom the median number of anticonvulsant drugs was three (IQR, 2-4). Twenty-one patients received thiopental in titrated doses followed by a continuous infusion, 17 received midazolam, and 16 received propofol (some patients received more than one anesthetic agent); nine patients had persistent nonconvulsive status epilepticus despite clinical control of seizure activity and required additional titrated doses targeting EEG burst suppression.
Total seizure duration was 85 mins (IQR, 46.5-180). At least one EEG was recorded in 191 (77%) patients, of whom 25 (13%) had electrical seizure activity without motor seizures. The proportion of patients who underwent an EEG according to GCS score at ICU admission was as follows: 135 (70.7%) with a GCS score of 3-8, 42 (22%) with a GCS score of 9 -14, and 13 (7.3%) with a GCS score of 15. Forty-three (87.7%) patients with refractory status epilepticus underwent an EEG. The most common causes of electrographic status epilepticus were as follows (one patient may have more than one diagnosis): stroke Computed tomography or magnetic resonance imaging was obtained in 224 (90%) patients. Lumbar puncture was performed in 132 (53%) patients who had a fever or clinical evidence suggesting meningitis. Cerebrospinal fluid was abnormal in 90 of the 132 (60.2%) patients who underwent lumbar puncture. Cerebrospinal fluid abnormalities were mainly related to patients with central nervous system infection and/or neoplasm involvement. For instance, these patients had an average cell count of 130/L (range, 0 -1500), average protein level of 12 mg/dL (range, 3-584), and average glucose level of 3.6 mmol/L (range, 0 -6.0). Strikingly, patients without meningeal involvement also presented with cerebrospinal fluid abnormalities. Namely, the average cell count was 27/L (range, 0 -799), average protein level was 59 mg/dL (range, 6 -348), and average glucose level was 4.9 mmol/L (range, 2.7-31.6).
Overall, the cause of convulsive status epilepticus was found in 206 (83%) patients. The most common cause was cerebral insult (37%) ( Table 3) .
Mechanical ventilation was needed in 210 (85%) patients, for 3 days (range, 2-6). The median Logistic Organ Dysfunction score was 6 (IQR, 4 -7), indicating a median of two organ failures per patient. Organ failures were as follows: neurologic in 237 (95.5%), respiratory in 199 (80.2%), renal in 83 (33.4%), hemodynamic in 78 (31.4%), hepatic in 21 (8.5%), and hematologic in 16 (6.5%).
Median ICU and hospital stay lengths were 5 days (IQR, 3-8) and 10 days (IQR, 5.7-24), respectively. ICU and hospital mortality rates were 11% (28 deaths) and 15% (38 deaths), respectively. During the 90-day follow-up period, four additional patients died, yielding an overall mortality rate of 19%. Among the 28 ICU deaths, 16 were thought to be related to convulsive status epilepticus: 11 in relation to its cause, one in relation to severity of cerebral impairment, and four in relation to multiple organ failure induced by uncontrolled seizure activity. Finally, among the 42 patients who died before hospital discharge, 16 died after decisions to forgo life-sustaining treatment (13 in the ICUs and 3 during hospital stay).
Ninety-Day Functional Outcome
The 90-day GOS score was known in 224 patients. Among them, 95 (42.2%) were alive with a GOS score of 5 (Fig. 1) . Table 4 reports the results of the univariate and multivariable analysis. Five factors were independently associated with a 90-day GOS score Ͻ5. Among them, three may be amenable to improvement, namely, longer seizure duration, presence of a cerebral insult, and progression to refractory status epilepticus (Fig. 2) . Figure 2A shows 90-day functional outcomes according to these three factors. A good recovery was achieved by 65% of patients with none of the three factors compared to only 8% of patients with all three factors (Fig. 2B) .
DISCUSSION
In this prospective multicenter study of 248 patients with convulsive status epilepticus managed in the ICU, 42 (18.8%) patients died before day 90 and only 95 (42.4%) had a good recovery defined as a GOS score of 5. Among factors independently associated with a poor outcome (GOS score, Ͻ5), three offer hope for preventive strategies.
Previous studies described the management and outcome of convulsive status epilepticus patients outside the ICU. They found high mortality rates (7, 8, 13, 21) and functional impairments (12, 13) and they identified age, comorbidities, and etiology of convulsive status epilepticus as determinants of death. Seizure duration was also a major determinant of death. However, these studies used various definitions of convulsive status epilepticus and did not report data on supportive care or organ dysfunction. In our prospective multicenter ICU study, we used the widely accepted operational definition of convulsive status epilepticus (1, 10, 23, 41) . Our design provides a picture of the presentation, management, and determinants of functional outcomes of convulsive status epilepticus meeting this new definition and managed in the ICU. The characteristics of the patients and seizures are in agreement with previous critical care studies. A majority (84%) of seizures were witnessed from the onset, allowing the collection of on-scene data and estimation of seizure duration. Total seizure duration was long (85 mins; IQR, 46.5-180), as previously described (42), despite the prompt response of the mobile medical teams (25) , with a median time to first drug administration of 40 mins (IQR, 0 -60). Consciousness was often severely impaired, with a median onscene GCS score of 5, in keeping with earlier data (10) . The proportion of patients with intermittent seizures (63%) was higher than previously reported (10), whereas the proportion of patients with refractory seizures (Ϸ20%) was lower (14, 43) . However, we did not include patients with postanoxic status epilepticus, a frequently refractory condition (14) . Finally, extensive investigations identified a cause in 83% of patients. e a Some patients had more than one diagnosis; b hyponatremia (n ϭ 9), hypernatremia (n ϭ 1), hypoglycemia (n ϭ 6), hyperammonemia (n ϭ 6), hypocalcemia (n ϭ 4), hypercalcemia (n ϭ 1), diabetic hyperglycemic hyperosmolar syndrome (n ϭ 1), hypoxemia (n ϭ 5), hyperhomocysteinemia (n ϭ 1); c medication adverse effects (n ϭ 5): Cyclosporine A (n ϭ 2), thalidomide (n ϭ 1), lidocaïne (n ϭ 1), isoniazid (n ϭ 1); Acute voluntary poisoning (n ϭ 8): Neuroleptic (n ϭ 3), t ricyclic antidepressant (n ϭ 4), lysergic acid amide (n ϭ 1); d after extensive investigations. e p Ͻ .05.
More than 30 yrs after the historical report of Aminoff et al (44) , the spectrum of status epilepticus etiologies according to existence or not of a preexisting seizure disorder remains unchanged. Anticonvulsant drug withdrawal was the most common cause in patients with previous epilepsy, whereas acute stroke dominated causes in inaugural convulsive status epilepticus. Finally, in keeping with previous ICU studies, cerebral insult was overall the most common cause (37% of patients) of status epilepticus (10, 14, 22) . We identified five factors independently associated with the 90-day functional outcome. Among them, three suggest avenues for improvement: total seizure duration, progression to refractory status epilepticus, and presence of a cerebral insult (45) (46) (47) . A good recovery on day 90 was noted in 65% of patients having none of these three factors compared to 8% of those having all three factors. Seizure duration was related to mortality in both retrospective and prospective studies of convulsive status epilepticus. However, the impact of seizure duration on the functional outcome, although suggested previously (14), had not been established based on prospective data. In a retrospective cohort study of adults with convulsive or nonconvulsive status epilepticus, refractoriness was significantly associated with GOS score deterioration over the course of the hospital stay (14) . The lower incidence of GOS score deterioration in this study (36%) may be chiefly related to the retrospective design (14) . In our study, the GOS score was evaluated prospectively by each investigator during a telephone interview. Cerebral insult was associated with poor functional outcomes in the aforementioned population (14, 22) and in another study that also used a retrospective design (12) . This factor is important because neuroprotection has been suggested as an adjuvant treatment of status epilepticus (48) , and several cerebral insults associated with convulsive status epilepticus may be candidates for this ap- proach. The other two factors associated with poor 90-day functional outcomes, age and focal neurologic signs at the onscene evaluation, cannot be influenced by earlier or different treatment.
All study ICUs followed current guidelines for managing convulsive status epilepticus (41) . Efforts to control the seizures and to identify their cause were started onscene, where intravenous anticonvulsant treatment was administered routinely, together with life-supporting measures if needed. Neurologic failure was present in all our patients, of whom 85% required mechanical ventilation. Furthermore, 89% of patients had at least one organ failure in addition to neurologic failure. Extensive diagnostic investigations were performed. Cerebral imaging and intermittent EEG monitoring were available for all patients if requested by the physician. The EEGs were interpreted by neurophysiologists, and neurologists assessed the patients as needed. Nevertheless, no cause was detected in 17% of patients.
Our study has several limitations. First, the extent to which our findings apply to the full spectrum of patients with convulsive status epilepticus is unclear. Some patients may have died before medical intervention and others may have recovered fully without needing ICU admission. Second, we defined convulsive status epilepticus using the recent operational definition of seizure activity lasting Ͼ10 mins, instead of 30 mins in the traditional definition. However, this operational definition is now widely used to encourage early intensification of anticonvulsant therapy in patients with prolonged seizures, before the phase of established status epilepticus (1) . Furthermore, it allowed us to compare our findings to previous data on convulsive status epilepticus (10) . Most patients presented with generalized convulsive status epilepticus, although approximately 25% had partial complex convulsive status epilepticus, which usually has a better prognosis. However, we aimed to include all critically ill patients with convulsive status epilepticus requiring ICU management, and all patients with partial complex convulsive status epilepticus had impaired consciousness on-scene. Third, the GOS is widely used to evaluate outcomes in patients with neurologic disorders. The GOS in its structured form has been found valid, practical, and reliable (15) , but indirect GOS evaluation via interviews of the patient's physician has not been studied. Fourth, there is no consensus definition of refractory status epilepticus, although most guidelines require persistent seizures despite at least two antiepileptic drugs (41) . However, our study was observational and, although the physicians were given recommendations, their prescription practices were not controlled. Thus, all patients with refractory status epilepticus received first-line anticonvulsant therapy and at least a second-line anticonvulsant drug before anesthesia induction. Fifth, some patients required immediate intubation on-scene because of life-threatening complications. In these cases, thiopental or propofol was perhaps used for rapidsequence induction. Although midazolam, propofol, and thiopental are not first-line agents for convulsive status epilepticus, they are considered first-line agents here because of their anticonvulsant effect. Sixth, despite extensive etiological investigations, 10% of patients did not undergo cerebral imaging. We cannot exclude the presence of structural lesions in these patients. Furthermore, even if EEG was used routinely in patients with persistent coma or suspected subtle status epilepticus, continuous EEG monitoring was not available in our study. Thus, we cannot exclude that some cases of conversion to nonconvulsive status epilepticus have been missed. Seventh, a GOS score of 4 may be viewed as a favorable outcome. A GOS score of 4 is "moderate disability" in a "patient capable of living independently but unable to return to work or school." This category is associated with functional impairments, because "some previous activities, either at work or in social life, are now no longer possible by reason of either physical or mental deficit." Thus, in keeping with other studies of outcomes of neurologic conditions in critically ill patients, we defined a poor outcome as a GOS score Ͻ5. This evaluation was also an opportunity to understand functional impairment. Thus, in the 182 survivors at day 90, 85 (46.7%) presented with sequelae distributed as follows: 27 with motor impairment, 41 with cognitive impairment, and 61 with onset or worsening of epilepsy. Unfortunately, none of the survivors underwent an accurate neuropsychological evaluation and quality of life Functional outcome on day 90 according to the three factors that were independently associated with a poor outcome and potentially amenable to improvement. Good recovery rate on day 90 (Glasgow Outcome Scale [GOS] score, 5) according to three independent factors identified by the multivariable analysis, namely, seizure duration Ͼ120 mins, cerebral insult, and refractory status epilepticus. A, Percentage of patients with a good recovery (GOS score, 5) according to whether the factors independently associated with a poor outcome were present or absent. B, Percentage of patients with a good recovery (GOS score, 5) according to the combination of factors independently associated with a poor outcome. SE, status epilepticus.
was not assessed so that sequalae after convulsive status epilepticus sequelae could be precisely detailed. Last, 90 days after ICU discharge may be early for determining the functional outcome. However, 90 days is the most widely used interval for assessing overall outcomes after brain injuries (14, 17, 18) . The 90-day interval was suitable for collecting data on function, which is a useful feature of our study because much of the earlier work focused on mortality.
CONCLUSIONS
In conclusion, 90 days after convulsive status epilepticus, only 42.4% of patients had achieved a good recovery and the outcome was predicted chiefly by factors available within a few hours after ICU admission. Among these factors, longer seizure duration, progression to refractory status epilepticus, and presence of cerebral insult may be amenable to improvement. Interventional studies are needed to measure the impact on functional outcomes of an early neuroprotective strategy aimed at shortening seizure duration and decreasing the incidence of refractory seizures. After completing this CME activity, participants should be better able to identify the etiology of convulsive status epilepticus, evaluate prognosis, and anticipate course of the disease.
